GraphWear develops an investigational wearable platform for continuous, needle-free monitoring of glucose and other disease-related biomarkers
GraphWear develops an investigational wearable platform for continuous, needle-free monitoring of glucose and other disease-related biomarkers. Its nanotechnology-based device measures molecules at the skin surface and is designed to provide real-time alerts and historical monitoring without blood or urine tests. The device is investigational and not available for sale in the U.S.